Related Experiment Video
Updated: Aug 11, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine
T Camou1, R Palacio, J L Di Fabio
1National Reference Laboratory, Montevideo, Uruguay.
Insights
A Streptococcus pneumoniae surveillance study in Uruguay found that 9- or 11-valent conjugate vaccines could prevent most invasive pneumococcal disease in children under five.
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- Streptococcus pneumoniae causes invasive infections in children.
- Serotype distribution of pneumococcal isolates varies geographically.
- Evaluating vaccine efficacy requires understanding local serotype prevalence.
Purpose of the Study:
- To assess the serotype distribution of invasive Streptococcus pneumoniae isolates in Uruguayan children.
- To evaluate the potential coverage of 7-, 9-, and 11-valent pneumococcal conjugate vaccines (PCVs).
- To determine the most suitable PCV formulation for Uruguay based on disease prevalence.
Main Methods:
- Surveillance of Streptococcus pneumoniae isolates from invasive infections in children aged <=5 years in Uruguay.
- Analysis of serotype distribution from 1994 to 2001.
- Comparison of isolate serotypes with coverage provided by 7-, 9-, and 11-valent PCVs.
Main Results:
- A total of 506 invasive isolates were analyzed.
- A 7-valent PCV would cover 49% of invasive isolates.
- A 9-valent PCV would cover 76%, and an 11-valent PCV would cover 86% of cases.
- All penicillin-resistant serotypes were included in the evaluated vaccine formulations.
Conclusions:
- The 9- or 11-valent PCVs offer significantly higher coverage for invasive pneumococcal disease in Uruguayan children compared to the 7-valent vaccine.
- These formulations also cover penicillin-resistant strains.
- The 9- or 11-valent vaccines are recommended if affordable for Uruguayan children.
Abstract:
An on-going Streptococcus pneumoniae surveillance in Uruguay furnished national information on serotype distribution of isolates from invasive infections in children =5 years. The adequacy of 7-, 9- and 11-valent conjugate vaccine formulations was evaluated, in comparison with the prevalence of the serotypes causing disease in this target population. From 1994 to 2001, 506 isolates were submitted to the National Reference Laboratory. The heptavalent vaccine would cover 49% of the invasive isolates, while the nonavalent vaccine would potentially prevent 76% of cases. The 11-valent vaccine would increase coverage to 86%. All the serotype/groups of penicillin-resistant isolates are included in the three conjugate vaccine formulations. The available data indicate that the 9- or the 11-valent vaccines, if affordable, are the most suitable formulations for Uruguayan children.
Related Concept Videos
Bacterial Meningitis
Streptococcal Pharyngitis
Poliomyelitis
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction

